Antisense and ribozymes have a relatively short yet successful history as research tools in gene expression studies, and thus are considered as having high potential reagents in treating viral infections and cancer. This laboratory companion provides detailed information on the potential, advantages and limitations of this methodology. It critically discusses potential pitfalls, presents strategies for choosing targets and delivery systems, so as to allow the selection of the optimum methodology for achieving fast and reliable experimental success with any human or other biological system. For researchers, technicians and advanced graduates in experimental medicine, molecular and cell biology. ![]()
Subscribe to:
Post Comments (Atom)
Popular posts
-
Pollack's book is extremely insightful, although sometimes controversial. It looks at cell biology from a unique viewpoint. After readin...
-
It's , easy to understand, very good graphics; Kuby is a very friendly book for new students, and for refreshing many concepts if you ar...
-
Do you find biochemistry daunting? If so, this time-saving guide offers all the help you need. Compact, yet comprehensive, the second editio...
-
Title: Dendritic Cells in Cancer Description: It covers all aspects of DC generation, function, survival and antitumor activity in the ...
-
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, ...
-
Updated for its Sixth Edition, this pocket manual is a practical, accessible, comprehensive guide to the management of patients with cancer....
-
A brief, clear, thorough, and highly enjoyable approach to clinical microbiology, brimming with mnemonics, humor, summary charts and illus...
-
Bioinformatics is an evolving field that is gaining popularity due to genomics, proteomics and other high-throughput biological methods. Th...
-
Crystallography is the major method of determining structures of biological macromolecules yet crystallization techniques are still regarded...
0 comments:
Post a Comment